|
|
???tair.name??? >
???browser.page.title.author???
|
"alberti a"???jsp.browse.items-by-author.description???
Showing items 1-6 of 6 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-04T06:24:14Z |
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
|
Schalm S.W.; Weiland O.; Hansen B.E.; Milella M.; Lai M.Y.; Hollander A.; Michielsen P.P.; Bellobuono A.; Chemello L.; Pastore G.; Chen D.-S.; Brouwer J.T.; Braconnier J.H.; Fryden A.; Norkrans G.; Reichard O.; Adler M.; Chamuleau R.A.F.M.; Delwaide J.; Elewaut A.; Fevery J.; Hautekeete M.L.; Nevens F.; Den Ouden-Muller J.W.; Wismans P.J.; Casalino C.; Maselli R.; Pietromatera G.; Chan K.W.; JIA-HORNG KAO; Ideo G.; Alberti A.; Cavalletto L.; Boot J.; Van Vliet C. |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti M.; Flisiak R.; JIA-HORNG KAO; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 國立臺灣大學 |
2013 |
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
|
Buti, M.; Flisiak, R.; Rasenack, J.; Davis, G.; Alberti, A.; Goeser, T.; Stanciu, C.; Chuang, W. -L.; Tabak, F.; Kao, J. -H.; Streinu-Cercel, A.; Hofstetter, G.; Wang, J.; Avila, C.; Orsenigo, R.; 高嘉宏 |
| 國立臺灣大學 |
2012 |
ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR
|
Alberti, A.; Chuang, W. -L.; Flisiak, R.; Mazzella, G.; Horban, A.; Goeser, T.; Calistru, P.; Buti, M.; Davis, G.; Gong, Y.; Avila, C.; Kao, J. -H.; 高嘉宏 |
| 臺大學術典藏 |
1999 |
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
|
Schalm, S.W.; Weiland, O.; Hansen, B.E.; Milella, M.; Lai, M.Y.; Hollander, A.; Michielsen, P.P.; Bellobuono, A.; Chemello, L.; Pastore, G.; Chen, D.-S.; Brouwer, J.T.; Braconnier, J.H.; Fryden, A.; Norkrans, G.; Reichard, O.; Adler, M.; Chamuleau, R.A.F.M.; Delwaide, J.; Elewaut, A.; Fevery, J.; Hautekeete, M.L.; Nevens, F.; Den Ouden-Muller, J.W.; Wismans, P.J.; Casalino, C.; Maselli, R.; Pietromatera, G.; Chan, K.W.; Kao, J.H.; Ideo, G.; Alberti, A.; Cavalletto, L.; Boot, J.; Van Vliet, C.; DING-SHINN CHEN; JIA-HORNG KAO |
Showing items 1-6 of 6 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
